Journal article · 2026

Identification of Novel RORγt Inverse Agonist YW-089 as a Preclinical Candidate for the Treatment of Autoimmune Diseases

Yafei Huang, Meiqi Song, Nannan Sun, Fazhi Yu, Ji’an Chen, Huimin Guo, Ting Tang, Mingcheng Yu, Yunpeng Zhao, Chenyu Zhu, 张卓君, Yonghui Wang and 1 more

Journal of Medicinal Chemistry · Published 12 November 2026 · DOI 10.1021/acs.jmedchem.6c01447

View at the publisherCite this paper

In brief

“Identification of Novel RORγt Inverse Agonist YW-089 as a Preclinical Candidate for the Treatment of Autoimmune Diseases” is a 2026 journal article by Yafei Huang and 12 co-authors, published in Journal of Medicinal Chemistry. OpenAlex counts 0 citations as of 18 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
0
References
42
Authors
13

Abstract

Retinoic acid receptor-related orphan receptor γt (RORγt) is a key regulator of IL-17-producing T helper 17 (Th17) cell differentiation and an attractive target for autoimmune diseases. Although RORγt inverse agonists have shown clinical promise, identifying candidates with both high potency and favorable drug-like properties remain challenging. We previously reported the carboxyl-containing biaryl urea compound 3i… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Huang, Y., Song, M., Sun, N., Yu, F., Chen, J., Guo, H., Tang, T., Yu, M., Zhao, Y., Zhu, C., 张卓君, Wang, Y., & Xie, Q. (2026). Identification of Novel RORγt Inverse Agonist YW-089 as a Preclinical Candidate for the Treatment of Autoimmune Diseases. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c01447

MLA 9

Huang, Yafei, et al. “Identification of Novel RORγt Inverse Agonist YW-089 as a Preclinical Candidate for the Treatment of Autoimmune Diseases.” Journal of Medicinal Chemistry, 2026. https://doi.org/10.1021/acs.jmedchem.6c01447.

Chicago

Huang, Yafei, Meiqi Song, Nannan Sun, Fazhi Yu, Ji’an Chen, Huimin Guo, Ting Tang, et al. 2026. “Identification of Novel RORγt Inverse Agonist YW-089 as a Preclinical Candidate for the Treatment of Autoimmune Diseases.” Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c01447.

Harvard

Huang, Y. et al. (2026) ‘Identification of Novel RORγt Inverse Agonist YW-089 as a Preclinical Candidate for the Treatment of Autoimmune Diseases’, Journal of Medicinal Chemistry. doi:10.1021/acs.jmedchem.6c01447.

IEEE

Y. Huang et al., “Identification of Novel RORγt Inverse Agonist YW-089 as a Preclinical Candidate for the Treatment of Autoimmune Diseases,” Journal of Medicinal Chemistry, 2026, doi: 10.1021/acs.jmedchem.6c01447.

BibTeX

@article{huang2026identification,
  title     = {{Identification of Novel RORγt Inverse Agonist YW-089 as a Preclinical Candidate for the Treatment of Autoimmune Diseases}},
  author    = {Huang, Yafei and Song, Meiqi and Sun, Nannan and Yu, Fazhi and Chen, Ji’an and Guo, Huimin and Tang, Ting and Yu, Mingcheng and Zhao, Yunpeng and Zhu, Chenyu and 张卓君 and Wang, Yonghui and Xie, Qiong},
  journal   = {Journal of Medicinal Chemistry},
  year      = {2026},
  doi       = {10.1021/acs.jmedchem.6c01447},
  url       = {https://doi.org/10.1021/acs.jmedchem.6c01447}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis

  • RORγt
  • inverse agonists
  • Th17 cell differentiation
  • IL-17
  • psoriasis
  • autoimmune disease
  • pharmacokinetics
  • oral bioavailability

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Huang, Y., Song, M., Sun, N., Yu, F., Chen, J., Guo, H., Tang, T., Yu, M., Zhao, Y., Zhu, C., 张卓君, Wang, Y., & Xie, Q. (2026). Identification of Novel RORγt Inverse Agonist YW-089 as a Preclinical Candidate for the Treatment of Autoimmune Diseases. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c01447

How many times has this paper been cited?

0 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Yafei Huang, Meiqi Song, Nannan Sun, Fazhi Yu, Ji’an Chen, Huimin Guo, Ting Tang, Mingcheng Yu, Yunpeng Zhao, Chenyu Zhu, 张卓君, Yonghui Wang and 1 more.

What is the DOI of this paper?

10.1021/acs.jmedchem.6c01447, permanently at https://doi.org/10.1021/acs.jmedchem.6c01447. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.